Navigation Links
Genetix Joins Molecular Devices: Combining Businesses to be in a Better Position to Serve Customers
Date:7/5/2011

SUNNYVALE, Calif., July 5, 2011 /PRNewswire/ -- Today, Molecular Devices, a leading provider of instruments, software, and consumables for drug discovery and life sciences research, announced that the Drug Discovery Division of Genetix will join Molecular Devices.

(Logo:  http://photos.prnewswire.com/prnh/20100406/SF82092LOGO)

With the addition of Genetix, Molecular Devices continues to grow as a leading technology supply company for research, biotechnology, and pharmaceutical customers around the world.

Research in Pharma/Biotech is shifting toward biotherapeutic drugs (antibodies, proteins, and vaccines).  Two key products from Genetix, the ClonePix™ and QPix™ instrument platforms, address cell lines used in biotherapeutic research.  ClonePix is an automated mammalian cell selection platform that significantly expedites the process of identifying and selecting cells that produce biotherapeutic candidates, reducing both time and cost.

In addition, the CloneSelect™ Imager and CellReporter from Genetix will extend Molecular Devices' imaging portfolio. These products offer a good value for a budget conscious end user.

Commenting on the move, Mark Verheyden, President of Molecular Devices said, "We are excited about welcoming Genetix into the Molecular Devices team, knowing that the combined business will be better positioned to serve our customers."

About Molecular Devices, Inc.

At Molecular Devices we have one focus—our customers. Whether a long-time user, recent adopter, or prospective customer, your needs fuel our actions. We hire creative, best-in-class people to design, manufacture, and commercialize analytical instruments, software, and assays as well as provide dedicated follow-on support. Understanding your laboratory workflow is our top priority, and we direct product development toward solving your unique issues. Our instruments offer a full spectrum of detection technologies and meet all throughput needs—from dedicated, single-readout devices to multi-readout systems. Our goal is to deliver highly relevant analytical products to detect biology, decode data, and drive discovery. With headquarters in Silicon Valley and offices around the globe, we support and enrich efforts of the international BioResearch, BioPharma, and BioTesting communities. Visit us today at www.MolecularDevices.com.

Molecular Devices products are for Research Use Only. Not for use in diagnostic procedures.

Molecular Devices, the Molecular Devices logo, and all other trademarks are the property of Molecular Devices, Inc.

About Genetix

Founded in 1991, Genetix offers cell selection and cell imaging instrumentation and related products to basic and applied research scientists. The product range has been rebranded to carry the Molecular Devices name.


'/>"/>
SOURCE Molecular Devices Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Imagenetix, Inc. Reports Third Quarter 2011 Results
2. Imagenetix, Inc. Provides Net Sales Guidance for the Second Quarter Fiscal 2011
3. Imagenetix Announces Issuance of New U.S. Patent for the Prevention and Treatment of Periodontal Disease
4. Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer
5. Bacterin Joins Russell 3000, Russell Microcap, and Russell Global Indexes
6. Drs. Ben Machielse Joins Omthera Pharmaceuticals, Inc. as Chief Operating Officer
7. Alan Dunton, M.D., Joins Board of Directors of Palatin Technologies, Inc.
8. Radient Pharmaceuticals Corporation Joins OTCQX
9. Dr. Assad Al-Ammar Joins Irvine Pharmaceutical Services as the New Minerals Analysis Manager in Response to the Growing Needs for USP Elemental Impurities Testing
10. Dr. F. John Mills Joins Intelsius Board of Directors as Non-Executive Chair
11. Mr. Charlie Alvarez Joins the Board of Sanomedics International Holdings, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... , Jan. 23, 2017  Delcath Systems, Inc. (NASDAQ: ... on the treatment of primary and metastatic liver cancers, ... MSN, CRNP, President and Chief Executive Officer of Delcath ... Noble Capital Markets, Thirteenth Annual Investor Conference at the ... Raton, Florida , on Tuesday, January 31, 2017 ...
(Date:1/23/2017)... Research and Markets has announced the addition of the ... to 2025" report to their offering. ... Report Highlights: The report provides ... investment opportunities Market forecasts till 2025, using estimated market ... the business segments, Regions and Countries Key developments and ...
(Date:1/23/2017)... DIEGO , Jan. 23, 2017  Using ... patients at high risk for acute kidney injury ... recommended by globally-recognized care guidelines significantly ... to severe AKI more than 33 percent, according ... in the journal Intensive Care Medicine. ...
Breaking Medicine Technology:
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... the premiere organization in North America for the scientific development, healthcare training and ... Annual Scientific Session, and its 2017 AAT Member Certification Qualification Courses for Technicians, ...
(Date:1/23/2017)... ... , ... "ProRandom is a set of camera tools that allow video editors to integrate up ... X," said Christina Austin - CEO of Pixel Film Studios. , With ProRandom, video ... footage. ProRandom works by using a virtual camera to create the illusion of a ...
(Date:1/23/2017)... ... 2017 , ... “Crossing the Bar”: a moving and eloquent drama depicting ... the Bar” is the creation of published author, Charlotte Hotte, a North Carolina native, ... the inspiration of the book to her sister, Denise, wishes to acknowledge her savior, ...
(Date:1/22/2017)... ... January 22, 2017 , ... Phytocéane invites clients to ... the rest of the world with ZANZIBAR MILKY CREAM. Inspired by the beauty of ... like Virgin Coconut Oil and moisturizing vegetal coral to create this gentle, velvety body ...
(Date:1/21/2017)... ... 21, 2017 , ... Salveo for life, a company that distributes an effervescent ... United States as part of its presence to expand its market reach. , Using ... the productions of nasty toxins as a result of drinking alcohol, eliminating those toxins ...
Breaking Medicine News(10 mins):